APA (7th ed.) Citation

Jacobsson, S., Golparian, D., Oxelbark, J., Franceschi, F., Brown, D., Louie, A., . . . Unemo, M. (2022). Pharmacodynamic Evaluation of Zoliflodacin Treatment of Neisseria gonorrhoeae Strains With Amino Acid Substitutions in the Zoliflodacin Target GyrB Using a Dynamic Hollow Fiber Infection Model. Frontiers in pharmacology, 13, 874176. https://doi.org/10.3389/fphar.2022.874176

Chicago Style (17th ed.) Citation

Jacobsson, Susanne, Daniel Golparian, Joakim Oxelbark, Francois Franceschi, David Brown, Arnold Louie, George Drusano, and Magnus Unemo. "Pharmacodynamic Evaluation of Zoliflodacin Treatment of Neisseria Gonorrhoeae Strains With Amino Acid Substitutions in the Zoliflodacin Target GyrB Using a Dynamic Hollow Fiber Infection Model." Frontiers in Pharmacology 13 (2022): 874176. https://doi.org/10.3389/fphar.2022.874176.

MLA (9th ed.) Citation

Jacobsson, Susanne, et al. "Pharmacodynamic Evaluation of Zoliflodacin Treatment of Neisseria Gonorrhoeae Strains With Amino Acid Substitutions in the Zoliflodacin Target GyrB Using a Dynamic Hollow Fiber Infection Model." Frontiers in Pharmacology, vol. 13, 2022, p. 874176, https://doi.org/10.3389/fphar.2022.874176.